Please login to the form below

Not currently logged in
Email:
Password:

PureTech Health appoints new chief financial officer

Joep Muijrers joins the biopharma from Life Sciences Partners

Joep MuijrersClinical-stage biopharmaceutical company PureTech Health has bolstered the team with a new chief financial officer in the form of Joep Muijrers.

Muijrers most recently served as a partner and portfolio manager at Life Sciences Partners, a trans-Atlantic investor group with an exclusive focus on the life science industry.

During his 11 years at the company, Muijrers’ responsibilities saw him help several companies strengthen its biopharmaceutical status.

Daphne Zohar, founder and chief executive officer of PureTech Health, said: “We are delighted to have Joep join PureTech Health and bring his diverse experience in life sciences and impressive track record of significant value creation to our team as we enter this next important phase of our growth.”

Muijrers has worked with pharmaceutical clients such as Kite Pharma, Ablynx and Juno Therapeutics, and said: “I am thrilled to join PureTech Health, one of the most exiciting and unique biopharma companies I have come across in my career.”

In his new role, Muijrers will be take the helm of all aspects of the company’s finances, including capital markets strategy and execution, driving monetisation events for growth stage affiliates, strategic and financial planning and financial reporting.

25th April 2018

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Publicis Resolute

Publicis Resolute provides real-life practical solutions to your issues, without fuss or fluff. We are an experienced team with a...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics